400 related articles for article (PubMed ID: 18358251)
1. Management of type 2 diabetes: oral agents, insulin, and injectables.
Fonseca VA; Kulkarni KD
J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
[TBL] [Abstract][Full Text] [Related]
2. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
Spellman CW
J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
[TBL] [Abstract][Full Text] [Related]
3. Therapy for type 2 diabetes mellitus.
Elson DF; Meredith M
WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes: stepped-care approach to patient management.
McFarland KF
Geriatrics; 1997 Oct; 52(10):22-6, 35, 39. PubMed ID: 9337803
[TBL] [Abstract][Full Text] [Related]
5. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
Gottesman I
Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
[TBL] [Abstract][Full Text] [Related]
6. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
7. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of the patient with type 2 diabetes.
Quinn L
Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
[TBL] [Abstract][Full Text] [Related]
11. [Insulin in the treatment of type 2 diabetes].
Meyer L; Guerci B; Ziegler O; Drouin P
Rev Prat; 1999 Jan; 49(1):51-5. PubMed ID: 9926717
[TBL] [Abstract][Full Text] [Related]
12. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
Tanenberg RJ
Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
14. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
15. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
16. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
Massi-Benedetti M; Orsini-Federici M
Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
[TBL] [Abstract][Full Text] [Related]
17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
Gao Y; Guo XH; Vaz JA;
Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
[TBL] [Abstract][Full Text] [Related]
18. Management of diabetes in the real world: tight control of glucose metabolism.
Spellman CW
J Am Osteopath Assoc; 2003 Aug; 103(8 Suppl 5):S8-13. PubMed ID: 12962204
[TBL] [Abstract][Full Text] [Related]
19. Understanding new pharmacologic therapy for type 2 diabetes.
Gutowski C
Nurse Pract; 1999 Jun; 24(6):15-8, 21-2, 24-5; quiz 26-7. PubMed ID: 10431294
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
McDonnell ME
J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
